Home Physical Sciences Crystal structure of ethyl 3-hydroxy-5-methyl-2-(4-(m-tolyl)-1H-1,2,3-triazol-1-yl)-[1,1′-biphenyl]-4- carboxylate, C25H24N3O3
Article Open Access

Crystal structure of ethyl 3-hydroxy-5-methyl-2-(4-(m-tolyl)-1H-1,2,3-triazol-1-yl)-[1,1′-biphenyl]-4- carboxylate, C25H24N3O3

  • Qiang Wang EMAIL logo , Lin Zhao , Wanli Xing , Chaozai Zong and Shuai Zhang
Published/Copyright: July 14, 2017

Abstract

C25H24N3O3, monoclinic, P21/c (no. 14), a = 9.4549(11) Å, b = 10.7640(12) Å, c = 21.279(3) Å, β = 98.778(2)°, V = 2140.2(4) Å3, Z = 4, Rgt(F) = 0.0498, wRref(F2) = 0.1408, T = 296(2) K.

CCDC no.:: 1536564

The crystal structure is shown in the figure. Tables 1 and 2 contain details on crystal structure and measurement conditions and a list of the atoms including atomic coordinates and displacement parameters.

Table 1

Data collection and handling.

Crystal:Yellow block
Size:0.2 × 0.2 × 0.1 mm
Wavelength:Mo Kα radiation (0.71073 Å)
μ:0.9 cm−1
Diffractometer, scan mode:Bruker APEXII, ω
2θmax, completeness:50.0°, >99%
N(hkl)measured, N(hkl)unique, Rint:11223, 3756, 0.051
Criterion for Iobs, N(hkl)gt:Iobs > 2 σ(Iobs), 2088
N(param)refined:284
Programs:Bruker [1] , SHELX [2, 3]
Table 2

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

AtomxyzUiso*/Ueq
C10.3376(3)1.0343(2)0.05762(12)0.0426(6)
C20.3998(3)1.0459(2)0.12172(12)0.0425(6)
C30.3512(3)0.9739(2)0.16836(11)0.0412(6)
C40.2450(3)0.8857(2)0.15322(12)0.0424(6)
C50.1902(3)0.8721(2)0.08930(12)0.0483(7)
H50.12110.81110.07810.058*
C60.2314(3)0.9429(2)0.04123(12)0.0443(7)
C70.1898(3)0.8064(2)0.20119(12)0.0460(7)
C80.1515(3)0.8547(3)0.25628(13)0.0578(8)
H80.16450.93890.26520.069*
C90.0939(3)0.7789(3)0.29839(14)0.0723(9)
H90.06790.81230.33530.087*
C100.0751(4)0.6547(3)0.28585(16)0.0778(10)
H100.03630.60410.31430.093*
C110.1133(4)0.6046(3)0.23168(16)0.0741(10)
H110.10140.52010.22340.089*
C120.1696(3)0.6807(2)0.18953(14)0.0578(8)
H120.19440.64680.15250.069*
C130.3889(3)1.1200(2)0.01174(13)0.0472(7)
C140.3509(3)1.2013(2)−0.09355(12)0.0566(8)
H14A0.44661.1842−0.10250.068*
H14B0.34721.2866−0.07920.068*
C150.2433(4)1.1801(3)−0.15101(14)0.0858(11)
H15A0.25081.0962−0.16540.129*
H15B0.26041.2366−0.18390.129*
H15C0.14911.1938−0.14080.129*
C160.1603(3)0.9160(3)−0.02537(13)0.0649(9)
H16A0.10140.9852−0.04120.097*
H16B0.10200.8430−0.02540.097*
H16C0.23200.9026−0.05210.097*
N30.4768(2)1.08661(19)0.32060(10)0.0536(6)
C180.5468(3)0.9755(2)0.32530(12)0.0429(6)
C190.6478(3)0.9405(2)0.38142(12)0.0455(7)
C200.6543(3)1.0063(2)0.43832(12)0.0528(7)
H200.59041.07130.44060.063*
C210.7527(3)0.9780(3)0.49132(13)0.0575(8)
C220.8459(3)0.8806(3)0.48652(15)0.0681(9)
H220.91360.85960.52140.082*
C230.8398(3)0.8139(3)0.43057(16)0.0684(9)
H230.90260.74820.42840.082*
C240.7423(3)0.8437(2)0.37834(13)0.0540(7)
H240.73960.79870.34090.065*
C250.7567(4)1.0503(3)0.55197(14)0.0811(10)
H25A0.82911.01650.58390.122*
H25B0.66531.04500.56620.122*
H25C0.77831.13570.54460.122*
N20.3995(2)1.09658(19)0.26430(10)0.0522(6)
N10.4201(2)0.99066(18)0.23284(9)0.0441(5)
C170.5095(3)0.9140(2)0.26894(12)0.0440(7)
H170.53980.83570.25810.053*
O10.5079(2)1.12501(17)0.14144(8)0.0561(5)
H10.52931.16280.11080.084*
O20.3137(2)1.11617(16)−0.04560(8)0.0578(5)
O30.4903(2)1.19018(17)0.02504(9)0.0608(6)

Source of material

To ethynyl-3-methylbenzene (63.8 mg, 0.55 mmol) and ethyl 4-azido-3-oxobutanoate (85.5 mg, 0.5 mmol) in t-BuOH/H2O (5 mL, V/V = 1/1) were added CuSO4⋅ 5H2O (26 μL, 1M, 5 mmol) and sodium ascorbate (9.9 mg, 10 mmol). The mixture was stirred at room temperature for 12 h. After completion monitoring by TLC, the mixture was charged with 1-buta-2,3-dien-1-one (79.3 mg, 0.55 mmol) and NaOH (40.0 mg, 1.0 mmol), stirred and heated at 80 °C for 1.5h. After cooling to room temperature, the reaction mixture was extracted with dichloromethane (3 × 15 mL), and the combined organic layers were dried over anhydrous Na2SO4 and concentrated in vacuum. The resulting residue was purified by flash chromatography (SiO2) using EtOAc/ petroleum ether (v/v = 1/5) as the solvent system to give the title compound (143.5 mg, 63%) as yellow solid. Single crystals were obtained by slow evaporation of its chloroform solution at room temperature.

Experimental details

All H atoms were placed in calculated positions and were included in the refinement in the riding model approximation, with Uiso(H) set to 1.2Ueq(C) and to 1.5Ueq(C) for methyl groups.

Discussion

1,2,3-Triazoles are heterocyclic compounds with a wide range of applications in medicinal chemistry, chemical biology, material science, and synthetic organic chemistry [4], [5], [6], [7], [8], [9], [10]. Among them, the 1-aryl-[1,2,3]-triazoles are key building units embedded in the lead compounds currently being developed as σ2 receptor ligands [11], Hsp90 inhibitors [12], suppressors of estrogen-related receptor α [13]. Owing to its larger conjugated system, coplanarity, and capability of hydrogen bonding, 1-aryl-[1,2,3]-triazoles play an important role in ionic recognition and design of chemical sensors [14]. Further, 1-aryl-[1,2,3]-triazoles are also indispensable intermediates for the preparation of a broad range of fine chemicals [15], [16], [17].

All bond lengths and angles of the title structure are in normal ranges. There is a 69.70(9)° dihedral angle between ring (C1—C6) and ring (N1—N3/C17—C18). The dihedral angle between the two benzene rings of biphenyl is 45.75(9)°.

Acknowledgement

This research project was supported by the Natural Science Research Program from Education Department of Henan Province (No. 2011 A150015).

References

Bruker AXS Inc., SAINT, APEX2, SHELXTL, Madison, Wisconsin, USA, 2009.Search in Google Scholar

Sheldrick, G. M.: A short history of SHELX. Acta Crystallogr. A64 (2008) 112–122.10.1107/S0108767307043930Search in Google Scholar PubMed

Sheldrick, G. M.: Crystal structure refinement with SHELXL. Acta Crystallogr. C71 (2015) 3–8.10.1107/S2053229614024218Search in Google Scholar PubMed PubMed Central

Vernekar, S. K. V.; Qiu, L.; Zhang, J.; Kankanala, J.; Li, H.; Geraghty, R. J.; Wang, Z.: 5′-Silylated 3′-1,2,3-triazolyl thymidine analogues as inhibitors of west nile virus and dengue virus. J. Med. Chem. 58 (2015) 4016–4028.10.1021/acs.jmedchem.5b00327Search in Google Scholar PubMed PubMed Central

Zhang, Y.; Ye, X.; Petersen, J. L.; Li, M.; Shi, X.: Synthesis and characterization of bis-N-2-aryl triazole as a fluorophore. J. Org. Chem. 80 (2015) 3664–3669.10.1021/acs.joc.5b00006Search in Google Scholar PubMed

Shi, S.; Kuang, C.: Palladium-catalyzed ortho-alkoxylation of 2-aryl-1,2,3-triazoles. J. Org. Chem. 79 (2014) 6105–6112.10.1021/jo5008306Search in Google Scholar PubMed

Lei, X.; Gao, M.; Tang, Y.: Tandem O–H Insertion/[1,3]-Alkyl shift of rhodium azavinyl carbenoids with benzylic alcohols: a route to convert C–OH bonds into C–C bonds. Org. Lett. 18 (2016) 4998–5001.10.1021/acs.orglett.6b02459Search in Google Scholar PubMed

Man, Z.; Dai, H.; Shi, Y.; Yang, D.; Li, C.: Synthesis of 5-iodo-1,2,3,4-tetrahydropyridines by rhodium-catalyzed tandem nucleophilic attacks involving 1-sulfonyl-1,2,3-triazoles and iodides. Org. Lett. 18 (2016) 4962–4965.10.1021/acs.orglett.6b02428Search in Google Scholar PubMed

Verma, Y. K.; Reddy, B. S.; Pawar, M. S.; Bhunia, D.; Kumar, H. M. S.: Design, synthesis, and immunological evaluation of benzyloxyalkyl-substituted 1,2,3-triazolyl α-GalCer analogues. ACS Med. Chem. Lett. 7 (2016) 172–176.10.1021/acsmedchemlett.5b00340Search in Google Scholar PubMed PubMed Central

Shieh, P.; Bertozzi, C. R.: Design strategies for bioorthogonal smart probes. Org. Biomol. Chem. 12 (2014) 9307–9320.10.1039/C4OB01632GSearch in Google Scholar

Bai, S.; Li, S.; Xu, J.; Peng, X.; Sai, K.; Chu, W.; Tu, Z.; Zeng, C.; Mach, R. H.: Synthesis and structure–activity relationship studies of conformationally flexible tetrahydroisoquinolinyl triazole carboxamide and triazole substituted benzamide analogues as σ2 receptor ligands. J. Med. Chem. 57 (2014) 4239–4251.10.1021/jm5001453Search in Google Scholar PubMed PubMed Central

Taddei, M.; Ferrini, S.; Giannotti, L.; Corsi, M.; Manetti, F.; Giannini, G.; Vesci, L.; Milazzo, F. M.; Alloatti, D.; Guglielmi, M. B.; Castorina, M.; Cervoni, M. L.; Barbarino, M.; Foderà, R.; Carollo, V.; Pisano, C.; Armaroli, S.; Cabri, W.: Synthesis and evaluation of new Hsp90 inhibitors based on a 1,4,5-trisubstituted 1,2,3-triazole scaffold. J. Med. Chem. 57 (2014) 2258–2274.10.1021/jm401536bSearch in Google Scholar PubMed

Xu, S.; Zhuang, X.; Pan, X.; Zhang, Z.; Duan, L.; Liu, Y.; Zhang, L.; Ren, X.; Ding, K.: 1-Phenyl-4-benzoyl-1H-1,2,3-triazoles as orally bioavailable transcriptional function suppressors of estrogen-related receptor α. J. Med. Chem. 56 (2013) 4631–4640.10.1021/jm4003928Search in Google Scholar PubMed

Cheng, C.; Wan, J.; Lin, M.; Liu, Y.; Lu, X.; Liu, J.; Xu, Y.; Chen, J.; Tu, Z.; Cheng, Y. E.; Ding, K.: Design, Synthesis, and in vitro biological evaluation of 1H-1,2,3-triazole-4-carboxamide derivatives as new anti-influenza A agents targeting virus nucleoprotein. J. Med. Chem. 55 (2012) 2144–2153.10.1021/jm2013503Search in Google Scholar PubMed

Stangenberg, R.; Türp, D.; Müllen, K.: Shape persistent hybrid dendrimers from benzene and triazole via click chemistry. Tetrahedron 70 (2014) 3178–3184.10.1016/j.tet.2014.03.037Search in Google Scholar

Li, Y.; Xu, L.; Yang, W. L.; Liu, H. B.; Lai, S. W.; Che, C. M.; Li, Y. L.: Amidetriazole: a versatile building block for construction of oxyanion anion receptors. Chem. Eur. J. 18 (2012) 4782–4790.10.1002/chem.201102760Search in Google Scholar PubMed

Sureshbabu, B.; Venkatachalam, R.; Sankararaman, S.: Substituent effect on the formation of helical to layered hydrogen bond networks in hydroxyl and carboxyl substituted 1-aryl-1H-1,2,3-triazoles. CrystEngComm 16 (2014) 6098–6106.10.1039/C4CE00738GSearch in Google Scholar

Received: 2017-3-7
Accepted: 2017-6-21
Published Online: 2017-7-14
Published in Print: 2017-9-26

©2017 Qiang Wang et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Articles in the same Issue

  1. Cover and Frontmatter
  2. Crystal structure of 2-(2-ethoxyphenyl)-7-propyl-5-methylimidazo[5,1-f][1,2,4]triazin-4(3H)-one, C17H20N4O2
  3. Crystal structure of catena-poly[aqua-(μ3-1,3,5-benzenetricarboxylato-κ3O:O′:O′′)-[μ3hydroxy-(1,3-di-(μ2-1,2,4-triazole-4-yl)benzoato-κ2N:N′)copper(II)], C19H16Cu2N6O9
  4. Crystal structure of poly[aqua-(μ3-3,5-di(4H-1,2,4-triazolyl-4-κ3N,N′:N′′)benzenecarboxylato)silver(I)], C11H9AgN6O3
  5. Crystal structure of tetrapropylammonium hydrogen carbonate, C13H29NO3
  6. Crystal structure of poly[μ2-acetato-κ3-O,O′:O′)diaqua(μ3-isophthalato-κ4O,O′:O′′:O′′′)yttrium(III)] monohydrate, C20H24O17Y2
  7. Crystal structure of catena-poly[dichlorido-(μ2-4-(1H-pyrazol-3-yl)-pyridine-κ2N,N′)]cadmium(II), C48H42Cd3Cl16N18
  8. Crystal structure of bis(tetraethylammonium) [1,1′-biphenyl]-2,2′-dicarboxylate trihydrate, C30H54N2O7
  9. Crystal structure of poly[(thiophene-3,4-dicarboxylato-κ1O)bis[1,2-bis(4-pyridyl)ethane-κ2N:N′]silver(I)] octahydrate, C30H42Ag2N4O12S
  10. The crystal structure of amine-(4-(1H-1,2,4-triazol-1-yl)benzoato-κN)silver(I) dihydrate, C9H13AgN4O4
  11. Crystal structure of poly[tetrakis(μ2-cyanido-κ2N:O)-cyanido-tris(pyridine)dicobalt(II/III)], C20H15Co2N8
  12. Crystal structure of bis(pyridine)-bis(2-formyl-4,6-dichlorophenolato)cobalt(II), C24H16Cl4CoN2O4
  13. Crystal structure of (E)-1-(4-(((E)-5-bromo-2-hydroxybenzylidene)amino)phenyl)ethan-1-one O-methyl oxime, C16H15BrN2O2
  14. Crystal structure of catena-poly[(μ2-3-(1H-pyrazol-4-yl)-5-(pyridin-4-yl)-1,2,4-triazole-κ N:N′)-bis(benzoato-κO)zinc(II)], C24H18N6O4Zn
  15. Hydrothermal synthesis and crystal structure of a poly[aqua-(μ4-4-(carboxylatomethyl)benzoato-κ4O:O′:O′′:O′′′)-(μ2-1-(4-(1H-imidazol-1-yl)benzyl)-1H-1,2,4-triazole-κ2N:N′) dimanganese(II)], [Mn2(C9H6O4)2(C12H11N5)(H2O)]
  16. Crystal structure of diaqua-catena-poly[diaqua-bis(μ2-5-(4-(1H-1,2,4-triazol-1-yl)phenyl)tetrazol-2-ido-κ2N:N′)cobalt(II)] dihydrate, C20H24CoN14O4
  17. Crystal structure of bis(μ3-2,2′-azanediylbis(ethan-1-olato)-κ5O:O,N,O′:O′)-tetrachlorido-bis(μ2-2-((2-hydroxyethyl)amino)ethan-1-olato-κ3N,O:O)dicobalt(II)dicobalt(III), C16H38Cl4Co4N4O8
  18. Crystal structure of poly[μ4-(4-(carboxylatomethyl)benzoato-κ4O:O′:O′′:O′′′)-(2-(4-(1H-imidazol-1-yl)phenyl)-1H-benzo[d]imidazole-κN)manganese(II)] [Mn(C9H6O4)(C16H12N4)]
  19. Crystal structure of 4-chloro-6-phenylpyrimidine, C10H7ClN2
  20. The crystal structure of [6-methoxy-2-(2,2,2-trifluoroacetyl)-3,4-dihydronaphthalen-1(2H)-one]difluoroborane, C13H10BF5O3
  21. Crystal structure of 3,3′-(butane-1,4-diylbis(azanylylidene))bis(1-phenylbut-1-en-1-olato)-κ4N,N′,O,O′]copper(II), C24H26N2O2Cu
  22. Crystal structure of tetraaqua-bis((E)-N′-(2-bromobenzylidene)isonicotinohydrazide-κN)zinc(II) dinitrate, C26H28N8O12Br2Zn
  23. Crystal structure of 2-amino-4-(4-bromophenyl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile, C16H13BrN2O2
  24. A single crystal study on tert-butyl-4-((4-(4-bromo-2-fluorophenylamino)-6-methoxyquinazolin-7-yloxy)methyl)piperidine-1-carboxylate, C26H30BrFN4O4
  25. Crystal structure of 1,1′-((1E,1′E)-(((ethane-1,2-diylbis(oxy))bis(2,1-phenylene))bis(azanylylidene))bis(methanylylidene))bis(naphthalen-2-olato-κ3O,O′,N)zinc(II), C36H26N2O4Zn
  26. Crystal structure of diaqua-bis(5′-(pyridin-1-ium-4-yl)-1H-[3,3′-bi(1,2,4-triazol)]-2′-ide-κ2N,N′)cobalt(II) — bis(5-(pyridin-4-yl-κN)-1H,1′H-3,3′-bi(1,2,4-triazole))octamolybdate – water (2/1/8), C27H33CoMo4N21O19
  27. Crystal structure of 3-cyclohexyl-2-(cyclohexylimino)-2,3-dihydro-6,8-diiodo-4H-1,3-benzoxazin-4-one, C20H24I2N2O2
  28. Crystal structure of dinitrato-κO-bis(tris((1H-benzo[d]imidazol-2-yl)methyl)amine-κ4N,N′,N′′,N′′′)-(μ2-cyclohexane-1,4-dicarboxylato-κ4O,O′:O′′,O′′′)dimanganese(II) – methanol – water (1/6/2), C62H80Mn2N16O18
  29. Crystal structure of bis(2-hydroxyethyl(phenyl)carbamodithioate)nickel(II), C18H20N2NiO2S4
  30. Crystal structure of methyl 1-(4-fluorobenzyl)-4-methoxy-5-oxopyrrolidine-3-carboxylate, C14H16FNO4
  31. Crystal structure of di-μ-iodido-bis(6-(p-tolyl)-2,2′-bipyridine-κ2N,N′)dicopper(I) — 2-(diphenylphosphoryl)benzoic acid (1/2), C36H29CuIN2O3P
  32. Crystal structure of 2-amino-4-(3-bromo-4-fluoro-phenyl)-7,7-dimethyl-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile, C18H16BrFN2O2
  33. Crystal structure of bis(μ2-2-chlorobenzoato-κ3O,O′:O′)-(2-chlorobenzoato-κO)-(2-chlorobenzoato-κO,O′)-bis(1,10-phenanthroline-κ2N,N′)-dicadmium(II) monohydrate, C52H36Cd2Cl4N4O10
  34. Crystal structure of 2-(8a-methyl-5-oxo-hexahydroimidazo [1,2-a]pyridin-1(5H)-yl)-2-oxoethyl acetate, C12H18N2O4
  35. Crystal structure of (E)-N,N-diethyl-2-(5-nitrothiazol-2-yl)-1-phenylethen-1-amine, C15H17N3O2S
  36. Crystal structure of diazido-dimethanolato-bis(μ2-2-(((3-oxidopropyl)imino)methyl)phenolato-κ4O:O,O′,N)dimanganese(III), C22H28Mn2N8O6
  37. The crystal structure of bis(2-(2,2,2-trifluoroacetyl)-3,4-dihydronaphthalen-1-olato-κ2O,O′)copper(II), C24H16CuF6O4
  38. Crystal structure of hexaaquanickel(II) bis((E)-4-((4-(dimethylamino)phenyl)diazenyl)benzenesulfonate), C28H40N6NiO12S2
  39. Crystal structure of catena-poly[aqua-(μ2-hexamethylenetetramine-κ2N:N′)-bis(2,6-difluorobenzoato-κ2O:O′)cadmium(II)]monohydrate, C20H22CdF4N4O6
  40. Crystal structure of 3-benzyl-2,3-dihydro-2-thioxoquinazolin-4(1H)-one, C15H12N2OS
  41. Crystal structure of bis(μ2-ferrocenecarboxylato-κ2O:O′)-bis(1,10-phenanthroline-κ2N,N′)-(μ2-methanolato2O,O)dicopper(II) tetrafluoroborate – acetonitrile (1/1), C49H40BCu2F4Fe2N5O5
  42. The crystal structure of tetrakis(1,3,5-triaza-7-phosphatricyclo[3.3.1.13,7]decane-κP)silver(I) chloride dihydrate, C24H60AgClN12O6P4
  43. Crystal structure of 5-ethyl-2-(p-tolyl)-1,3-dioxane-5-carboxylic acid, C14H18O4
  44. Crystal structure of 2-(4-fluorophenyl)-1,3-dimethyl-1H-perimidin-3-ium iodide, C19H16ClIN2
  45. Crystal structure of catena-poly[(μ2-hexamethylenetetramine-κ2N:N′)-tetrakis(μ2-2,6-difluorobenzoato-κ2O:O′)dicopper(II)], C34H24Cu2F8N4O8
  46. Crystal structure of ethyl 3-hydroxy-5-methyl-2-(4-(m-tolyl)-1H-1,2,3-triazol-1-yl)-[1,1′-biphenyl]-4- carboxylate, C25H24N3O3
  47. The crystal structure of carbonyl(2-oxopyridin-1(2H)-olato-κ2O,O′)-(diphenylcyclohexylphosphine-κP)rhodium(I), C24H25NO3PRh
  48. Crystal structure of bis((pyrazin-2-ylmethyl)(pyrazine-2-carbonyl)amido-κ3N,N′,N′′)copper(II), C20H16CuN10O2
  49. Crystal structure of catena-poly[tetraaqua-(μ2-succinonitrile-κ2N:N′)cobalt(II)] dinitrate, C4H12CoN4O10
  50. The crystal structure of 1,1′-bisisoquinoline, C18H12N2
  51. Crystal structure of bis(hydroxydi(pyridin-2-yl)methanolato-κ3N,N′,O)cobalt(III) perchlorate dihydrate, C22H22ClCoN4O10
Downloaded on 20.1.2026 from https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2017-0065/html
Scroll to top button